Fox Run Management’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-23,770
Closed -$92K 1085
2024
Q4
$92K Buy
23,770
+68
+0.3% +$263 0.02% 813
2024
Q3
$155K Buy
+23,702
New +$155K 0.03% 699